Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Polysaccharide iron complex capsules for iron deficiency anemia due to uterine fibroid-related abnormal uterine bleeding
ChiCTR2300073910Phase 4Completed
- Sponsor
- Beijing Obstetric & Gynecology Hospital, Capital Medical University
- Start
- Jul 2023
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of iron polysaccharide complex in iron deficiency anemia (IDA), menstrual disorders and Fibromyoma (LM), sponsored by Beijing Obstetric & Gynecology Hospital, Capital Medical University. Primary endpoints: Hemoglobin (Hb) and red blood cell count (RBC), Serum iron (SI) and 3 more. Started Jul 2023; status: completed.
02
Drugs
iron polysaccharide complex
03
Conditions
iron deficiency anemia (IDA)menstrual disordersFibromyoma (LM)
Beyond the preview
Go deeper on ChiCTR2300073910.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300073910.